<bill session="110" type="h" number="2823" updated="2013-07-19T21:28:32-04:00">
  <state datetime="2007-06-21">REFERRED</state>
  <status>
    <introduced datetime="2007-06-21"/>
  </status>
  <introduced datetime="2007-06-21"/>
  <titles>
    <title as="introduced" type="short">Fair Balance Prescription Drug Advertisement Act of 2007</title>
    <title as="introduced" type="official">To amend the Internal Revenue Code of 1986 to deny any deduction for direct-to-consumer advertisements of prescription drugs that fail to provide certain information or to present information in a balanced manner, to amend the Federal Food, Drug, and Cosmetic Act to require reports regarding such advertisements, and to amend such Code to deny any deduction for direct-to-consumer advertisements of qualified prescription drugs for a two-year period.</title>
  </titles>
  <sponsor id="400387"/>
  <cosponsors/>
  <actions>
    <action datetime="2007-06-21">
      <text>Sponsor introductory remarks on measure.</text>
      <reference ref="CR E1375"/>
    </action>
    <action state="REFERRED" datetime="2007-06-21">
      <text>Referred to the Committee on Ways and Means, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.</text>
    </action>
    <action datetime="2007-06-21">
      <text>Referred to House Ways and Means</text>
    </action>
    <action datetime="2007-06-21">
      <text>Referred to House Energy and Commerce</text>
    </action>
    <action datetime="2007-06-21">
      <text>Referred to the Subcommittee on Health.</text>
      <committee name="House Energy and Commerce"/>
    </action>
  </actions>
  <committees>
    <committee code="HSWM" name="House Ways and Means" activity="Referral, In Committee"/>
    <committee code="HSIF" name="House Energy and Commerce" activity="Referral, In Committee"/>
    <committee activity="Referral" code="HSIF14" subcommittee="Health" name="House Energy and Commerce"/>
  </committees>
  <relatedbills/>
  <subjects>
    <term name="Health"/>
    <term name="Commerce"/>
    <term name="Consumer education"/>
    <term name="Corporation taxes"/>
    <term name="Deceptive advertising"/>
    <term name="Drug advertising"/>
    <term name="Drug industry"/>
    <term name="Drugs"/>
    <term name="Government operations and politics"/>
    <term name="Government paperwork"/>
    <term name="Income tax"/>
    <term name="Labeling"/>
    <term name="Tax deductions"/>
    <term name="Taxation"/>
  </subjects>
  <amendments/>
  <summary>6/21/2007--Introduced.
Fair Balance Prescription Drug Advertisement Act of 2007 - Amends the Internal Revenue Code to disallow a tax deduction for: (1) expenses for direct-to-consumer prescription drug advertising that fails to provide adequate information on drug side effects, contraindications, or lack of effectiveness; and (2) expenses for direct-to-consumer prescription drug advertising of a new drug, a new combination of active substances, or a new delivery system for an existing drug for a two-year period after the introduction of such drug into interstate commerce.Amends the Federal Food, Drug, and Cosmetic Act to require the Secretary of Health and Human Services to report to the Secretary of the Treasury on misbranding and other violations relating to direct-to-consumer prescription drug advertising.</summary>
</bill>
